35 results on '"Zembala, M."'
Search Results
2. ADVANCED GLYCATION END-PRODUCTS (AGES) IN DEVELOPMENT OF ISCHEMIC AND DILATED CARDIOMYOPATHY IN PATIENTS WITH DIABETES MELLITUS TYPE 2 (DM).
3. Abdominal complications associated with cardiac surgery.
4. FACTORS INFLUENCING TIME OF ONSET OF TRANSPLANTED HEART CORONARY ARTERY DISEASE.
5. INFLUENCE OF IMMUNOPHILLINS INHIBITORS - CYCLOSPORINE-A, TACROLIMUS AND RAPAMYCIN - ON INSULIN SECRETION IN HEART TRANSPLANT RECIPIENTS WITH DIABETES.
6. Formation of Insoluble Advanced Glycation End Products Deposits in Connective Tissue of Hearts Explanted Prior to Transplantation Is Enhanced both by Heart Failure and Diabetes.
7. THE EFFECT OF EVEROLIMUS INTRODUCTION ON RENAL FUNCTION IN HEART TRANSPLANT RECIPIENTS.
8. ADVANCED GLYCATION END-PRODUCTS (AGES) IN LATE PATHOLOGY OF TRANSPLANTED HEART IN PATIENTS WITH OR WITHOUT DIABETES MELLITUS TYPE 2 (DM).
9. EARLY STEROID WITHDRAWAL HAS BAD IMPACT ON DIABETES MELLITUS (DM) AND KIDNEY FUNCTION.
10. DO HEART TRANSPLANT RECIPIENTS WITH PULMONARY HYPERTENSION BENEFIT FROM PERIOPERATIVE ORAL SILDENAFIL TREATMENT?
11. PATIENTS ON LONG-TERM BETACEPTOR-ANTAGONIST TREATMENT WITH PEAK OXYGEN CONSUMPTION ABOVE THE CUT-OFF POINT FOR HEART TRANSPLANTATION LISTING HAVE WORSE SURVIVAL IF A RESTRICTIVE PATTERN IN LUNG FUNCTION TESTS OCCURES.
12. FLUCTUATIONS OF EXERCISE CAPACITY IN PATIENTS AFTER KIDNEY TRANSPLANTATION.
13. SURVIVAL BENEFIT IN HEART TRANSPLANT RECIPIENTS WITH CORONARY ARTERY DISEASE CONFIRMED IN ANGIOGRAPHY RECEIVING SIROLIMUS.
14. HOW TO USE SIROLIMUS IN ORDER TO INCREASE SURVIVAL IN HEART TRANSPLANT RECIPIENTS?
15. CARDIOCYTE NUCLEAR CHROMATIN DENSITY CORRELATES WITH TRANSPLANTED HEART LEFT VENTRICULAR MASS.
16. Delirium after coronary artery bypass graft surgery. Evaluation of preliminary predictors based on an analysis of 931 patients.
17. Standard and strict (adjusted) chronic obstructive pulmonary disease (COPD) criteria and the risk of postoperative complications following coronary artery bypass surgery (CABG).
18. Impact of diabetes on perioperative outcome in patients following isolated mitral valve surgery - preliminary results.
19. Perioperative outcome in oral-treated and insulin-treated diabetic patients following coronary artery surgery.
20. Remifentanil and fentanyl during induction of anaesthesia for coronary artery surgery.
21. OPCAB, CABG and cost of ICU stay after cardiac surgery.
22. EUROscore and cost of ICU stay after cardiac surgery.
23. CLUE FACTORS IN ACHIEVEMENT OF 10-YEAR SURVIVAL AFTER ORTHOTOPIC HEART TRANSPLANTATION (OHT).
24. THE APOPTOSIS-RELATED SOLUBLE MOLECULES CONCENTRATION IN HEART TRANSPLANT RECIPIENTS RECEIVING TACROLIMUS OR CYCLOSPORINE-A - PILOT STUDY.
25. COMPARISON OF EARLY FUNCTION OF HEART AND KIDNEYS HARVESTED FROM THE SAME DONOR AND TRANSPLANTED INTO DIFFERENT RECIPIENTS.
26. USEFULNESS OF STANFORD SCALE OF INTIMAL HYPERPLASIA ASSESSED BY INTRAVASCULAR ULTRASOUND TO PREDICT TIME OF ONSET AND SEVERITY OF TRANSPLANTED HEART CORONARY ARTERY DISEASE.
27. CHIMERISM OF HUMAN CARDIAC ALLOGRAFT.
28. USEFULNESS OF PULMONARY HYPERTENSION REVERSIBILITY TEST WITH SODIUM NITROPRUSSIDE (NPS) IN STRATIFICATION OF EARLY DEATH RISK AFTER ORTHOTOPIC HEART TRANSPLANTATION (OHT).
29. LONGER ISCHAEMIC TIME CAUSED BY A DISTANCE BETWEEN THE DONOR HOSPITAL AND TRANSPLANT CENTER DOES NOT INFLUENCE SHORT AND LONG TERM RESULTS OF HEART TRANSPLANTATION.
30. Does Prostaglandine E2 Analogue Protect Liver Cell in Experimental Septic Syndrome.
31. Nanocrystalline-Coated Silver Dressings for Patients with Type 2 Diabetes after Surgical Coronary Revascularization.
32. Society of Thoracic Surgeons Risk Score and EuroSCORE-2 Appropriately Assess 30-Day Postoperative Mortality in the STICH Trial and a Contemporary Cohort of Patients With Left Ventricular Dysfunction Undergoing Surgical Revascularization.
33. Influence of Baseline Characteristics, Operative Conduct, and Postoperative Course on 30-Day Outcomes of Coronary Artery Bypass Grafting Among Patients With Left Ventricular Dysfunction: Results From the Surgical Treatment for Ischemic Heart Failure (STICH) Trial.
34. Effect of the immunomodulating agent, pentoxifylline, in the treatment of sepsis in prematurely delivered infants: a placebo-controlled, double-blind trial.
35. Impairment of B-lymphocyte differentiation induced by dual triggering of the B-cell antigen receptor and CD40 in advanced HIV-1-disease.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.